Liposomal Bupivacaine in One-level Instrumented Posterior Spinal Fusion
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This study will describe postoperative pain management for spine surgery patients receiving
liposomal bupivacaine (Exparel®) compared to patients not receiving the drug.